The multi-functional eyes absent proteins.
DNA damage repair
EYA
Eyes Absent
H2AX
MYC
Notch
PTP
threonine phosphatase
Journal
Critical reviews in biochemistry and molecular biology
ISSN: 1549-7798
Titre abrégé: Crit Rev Biochem Mol Biol
Pays: England
ID NLM: 8903774
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
pubmed:
31
7
2020
medline:
28
5
2021
entrez:
31
7
2020
Statut:
ppublish
Résumé
The Eyes Absent (EYA) proteins are the only known instance of a single polypeptide housing the following three separable biochemical activities: tyrosine phosphatase, threonine phosphatase, and transactivation. This uniquely positions the EYAs to participate in both transcriptional regulation and signal transduction pathways. But it also complicates the assignment of biological roles to individual biochemical activities through standard loss-of-function experiments. Nevertheless, there is an emerging literature linking developmental and pathological functions with the various EYA activities, and a growing list of disease states that might benefit from EYA-targeted therapeutics. There also remain multiple unresolved issues with significant implications for our understanding of how the EYAs might impact such ubiquitous signaling cascades as the MYC and Notch pathways. This review will describe the unique juxtaposition of biochemical activities in the EYAs, their interaction with signaling pathways and cellular processes, emerging evidence of roles in disease states, and the feasibility of therapeutic targeting of individual EYA activities. We will focus on the phosphatase activities of the vertebrate EYA proteins and will examine the current state of knowledge regarding: • substrates and signaling pathways affected by the EYA tyrosine phosphatase activity; • modes of regulation of the EYA tyrosine phosphatase activity; • signaling pathways that implicate the threonine phosphatase activity of the EYAs including a potential interaction with PP2A-B55α; • the interplay between the two phosphatase activities and the transactivation function of the EYAs; • disease states associated with the EYAs and the current state of development of EYA-targeted therapeutics.
Identifiants
pubmed: 32727223
doi: 10.1080/10409238.2020.1796922
pmc: PMC7727457
mid: NIHMS1648379
doi:
Substances chimiques
Trans-Activators
0
Phosphoprotein Phosphatases
EC 3.1.3.16
Protein Tyrosine Phosphatases
EC 3.1.3.48
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Review
Video-Audio Media
Langues
eng
Sous-ensembles de citation
IM
Pagination
372-385Subventions
Organisme : NCI NIH HHS
ID : R01 CA207068
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL152094
Pays : United States
Références
Biochem J. 2007 Feb 15;402(1):1-15
pubmed: 17238862
J Clin Invest. 2014 Aug;124(8):3378-90
pubmed: 24960160
J Biochem. 2011 Oct;150(4):345-56
pubmed: 21856739
Nature. 2003 Nov 20;426(6964):295-8
pubmed: 14628052
Mol Cell Biol. 2013 Mar;33(5):927-36
pubmed: 23263983
Cell Cycle. 2014;13(1):62-71
pubmed: 24196439
J Assoc Res Otolaryngol. 2004 Sep;5(3):295-304
pubmed: 15492887
Dev Cell. 2009 Feb;16(2):271-9
pubmed: 19217428
Front Oncol. 2019 Jan 29;9:26
pubmed: 30761270
Oncogene. 2010 Jun 24;29(25):3715-22
pubmed: 20418914
FEBS Lett. 2006 Jul 10;580(16):3853-9
pubmed: 16797546
Cell Mol Life Sci. 2013 Jun;70(11):1897-913
pubmed: 22971774
Int J Mol Sci. 2019 Dec 13;20(24):
pubmed: 31847183
Nat Cell Biol. 2005 Jan;7(1):21-9
pubmed: 15580268
Oncogene. 2012 Feb 2;31(5):552-62
pubmed: 21706047
Nucleic Acids Res. 2019 Jul 9;47(12):6299-6314
pubmed: 31045206
Biol Open. 2015 May 15;4(7):873-84
pubmed: 25979708
J Exp Clin Cancer Res. 2017 Aug 3;36(1):102
pubmed: 28774341
Mol Syst Biol. 2011 Oct 11;7:539
pubmed: 21988835
Development. 2003 Jul;130(13):3053-62
pubmed: 12756186
Annu Rev Biochem. 2007;76:513-38
pubmed: 17341163
Proc Natl Acad Sci U S A. 1980 Mar;77(3):1311-5
pubmed: 6246487
J Biol Chem. 2009 Jun 12;284(24):16066-70
pubmed: 19351884
Hum Mol Genet. 2000 Feb 12;9(3):363-6
pubmed: 10655545
PLoS One. 2012;7(4):e34806
pubmed: 22545090
Biochemistry. 2005 Jan 18;44(2):751-8
pubmed: 15641802
J Clin Invest. 2008 Feb;118(2):651-8
pubmed: 18219393
PLoS One. 2013 Dec 18;8(12):e84582
pubmed: 24367676
Cell Rep. 2014 Sep 11;8(5):1583-94
pubmed: 25159151
Cell. 1997 Dec 26;91(7):881-91
pubmed: 9428512
Oncotarget. 2017 Sep 27;8(62):105081-105092
pubmed: 29285235
Cell. 2004 Jun 11;117(6):699-711
pubmed: 15186772
Proc Natl Acad Sci U S A. 1997 Oct 28;94(22):11974-9
pubmed: 9342347
Stem Cell Res Ther. 2020 May 26;11(1):200
pubmed: 32456711
Nat Commun. 2018 Mar 13;9(1):1047
pubmed: 29535359
Mol Cancer Ther. 2018 Aug;17(8):1659-1669
pubmed: 29802120
Dev Cell. 2014 Nov 24;31(4):434-47
pubmed: 25458011
Elife. 2017 Nov 15;6:
pubmed: 29140246
Nature. 2003 Nov 20;426(6964):299-302
pubmed: 14628053
Curr Biol. 2006 Apr 4;16(7):660-7
pubmed: 16581510
Mol Cell Biol. 2016 Dec 19;37(1):
pubmed: 27795300
Mol Cancer Res. 2012 Aug;10(8):1098-108
pubmed: 22723308
Dev Biol. 2007 Oct 15;310(2):416-29
pubmed: 17714699
Mol Cell Biol. 1999 Oct;19(10):6815-24
pubmed: 10490620
Nat Cell Biol. 2004 Apr;6(4):308-18
pubmed: 15048125
Int J Biochem Cell Biol. 2018 Mar;96:171-181
pubmed: 28943273
Nature. 2003 Nov 20;426(6964):247-54
pubmed: 14628042
Chembiochem. 2008 Sep 22;9(14):2285-94
pubmed: 18759246
Mol Cancer Ther. 2019 Sep;18(9):1484-1496
pubmed: 31285279
Dev Cell. 2015 Apr 6;33(1):22-35
pubmed: 25816987
BMC Cancer. 2017 May 18;17(1):338
pubmed: 28521819
Sci Rep. 2018 Feb 13;8(1):2910
pubmed: 29440662
Dev Biol. 1998 Apr 1;196(1):42-57
pubmed: 9527880
J Cancer Res Ther (Manch). 2016 Jun;4(2):11-18
pubmed: 28713571
Curr Opin Cell Biol. 2001 Apr;13(2):182-95
pubmed: 11248552
Cancer Res. 2013 Jul 15;73(14):4488-99
pubmed: 23636126
Nature. 2009 Jan 1;457(7225):57-62
pubmed: 19092802
Nature. 2009 Jul 23;460(7254):520-4
pubmed: 19561593
FEBS Lett. 2011 Sep 2;585(17):2714-9
pubmed: 21821028
DNA Repair (Amst). 2015 Aug;32:180-189
pubmed: 25956861
Nat Commun. 2019 Sep 12;10(1):4143
pubmed: 31515519
Nat Commun. 2018 Jul 16;9(1):2736
pubmed: 30013081
Mol Cell Biol. 2006 Apr;26(7):2832-44
pubmed: 16537924
Oncogene. 2010 Jan 21;29(3):368-79
pubmed: 19901965
J Cell Sci. 2013 May 15;126(Pt 10):2135-40
pubmed: 23729744
Elife. 2020 Mar 06;9:
pubmed: 32142407
Nature. 2009 Apr 2;458(7238):591-6
pubmed: 19234442
Am J Pathol. 2016 Mar;186(3):568-78
pubmed: 26765957
Nat Med. 2009 May;15(5):553-8
pubmed: 19377486
J Clin Invest. 2018 Jun 1;128(6):2535-2550
pubmed: 29757193
Dev Biol. 2013 Oct 1;382(1):110-23
pubmed: 23895934
PLoS One. 2012;7(8):e42725
pubmed: 22916150
J Biomol Screen. 2013 Jan;18(1):85-96
pubmed: 22820394